Despite these hurdles, the study highlights BPC 157 as a highly promising but still experimental therapy that requires more research, especially in humans, before it can be widely recommended for medical use
Treatment response depends on deficiency severity, route of administration, underlying cause, patient age, concurrent medical conditions, and medication interactions
Some people have a lack of IF and thus an impaired ability to absorb B12, often as a result of pernicious anaemia being an autoimmune condition that attacks the cells in the stomach
Scientific Evidence for Soft Tissue Repair The scientific literature on BPC-157 contains hundreds of studies, though the vast majority involve animal models rather than human subjects
B12 Shots injections allow direct and immediate absorption to the bloodstream